conjupepdb_log

Browse Conjugates

Showing all from all years

Select the artile year range to filter. Press the Clear button to clear all the selections.
Filters Help Icon ConjuPepDB ID CAS RN Peptide name Sequence (one letter) Small molecule Application Conjugate Type Reference

Article year


cpd009621204583-18-5octargininRRRRRRRR(8S,10S)-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-NaphthacenedioneAnticancer therapy, leukemia and hepatomaamide Zsanett MiklÃet.al (2009)

DOI

cpd009631204583-17-4hexargininRRRRRR(8S,10S)-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-NaphthacenedioneAnticancer therapy, leukemia and hepatomaamide Zsanett MiklÃet.al (2009)

DOI

cpd009641204583-16-3octargininRRRRRRRR(8S,10S)-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-NaphthacenedioneAnticancer therapy, leukemia and hepatomaother Zsanett MiklÃet.al (2009)

DOI

cpd009651204583-15-2hexargininRRRRRR(8S,10S)-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(1-hydrazonoethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-NaphthacenedioneAnticancer therapy, leukemia and hepatomaother Zsanett MiklÃet.al (2009)

DOI

cpd009661202406-16-3GGGPKKKRKVGG(T-4)-[4-[(3,5-dimethyl-1H-pyrrol-2-yl-κN)(3,5-dimethyl-2H-pyrrol-2-ylidene-κN)methyl]phenolato]difluoro-boronAnticancer therapytriazole Joshua C.et.al (2009)

DOI

cpd009671202406-15-2GGGPKKKXKVGG(T-4)-[4-[(3,5-dimethyl-1H-pyrrol-2-yl-κN)(3,5-dimethyl-2H-pyrrol-2-ylidene-κN)methyl]phenolato]difluoro-boronAnticancer therapytriazole Joshua C.et.al (2009)

DOI

cpd009681202186-29-5GGGPKKKRKVGG2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acidAnticancer therapysulfonamide Joshua C.et.al (2009)

DOI

cpd009691202186-25-1GGGPKKKXKVGG2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acidAnticancer therapysulfonamide Joshua C.et.al (2009)

DOI

cpd009701202186-24-0GGGPKKKXKVGG2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acidAnticancer therapysulfonamide Joshua C.et.al (2009)

DOI

cpd009711202186-23-9GGGPKKKXKVGG2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuransulfonic acidAnticancer therapysulfonamide Joshua C.et.al (2009)

DOI

cpd00972960395-13-5KTTKSL-Ascorbic acidCosmetic ingredient and wound healing agentamide Ho-et.al (2009)

DOI

cpd009731191457-17-6CNGRCPplatinum-(SP-4-2)-(1,2-Ethanediamine-κN1,κN2)[propanedioato(2-)-κO1,κO3]Anticancer therapyamide Ndinguri, Margaret W.et.al (2009)

DOI

cpd009741191457-16-5CNGRCPlatinum-(SP-4-2)-[2-(3-aminopropyl)propanedioato(2-)-κO1,κO3]diammineAnticancer therapyamide Ndinguri, Margaret W.et.al (2009)

DOI

cpd009751190704-99-4QACKGKIQALCENGCarbamic acid, N-[(3α,5β,7α,12α)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl esterAnticancer therapyamide Bode, Catherine A.et.al (2009)

DOI

cpd009761190704-98-3QACKGKIQALCENGCarbamic acid, N-[(3α,5β,7α,12α)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl esterAnticancer therapyamide Bode, Catherine A.et.al (2009)

DOI

cpd009771190704-97-2QACKGKIQALCENGCarbamic acid, N-[(3α,5β,7α,12α)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl esterAnticancer therapyamide Bode, Catherine A.et.al (2009)

DOI

cpd009781190704-96-1QACKGKIQALCENGCarbamic acid, N-[(3α,5β,7α,12α)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl esterAnticancer therapyamide Bode, Catherine A.et.al (2009)

DOI

cpd009791190704-95-0QACKGKIQALCENGCarbamic acid, N-[(3α,5β,7α,12α)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl esterAnticancer therapyamide Bode, Catherine A.et.al (2009)

DOI

cpd009801190704-94-9QACKGKIQALCENGCarbamic acid, N-[(3α,5β,7α,12α)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl esterAnticancer therapyamide Bode, Catherine A.et.al (2009)

DOI

cpd009811190704-93-8QACKGKIQALCENGCarbamic acid, N-[(3α,5β,7α,12α)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl esterAnticancer therapyamide Bode, Catherine A.et.al (2009)

DOI

cpd009821190704-92-7QACKGKIQALCENGCarbamic acid, N-[(3α,5β,7α,12α)-7-(acetyloxy)-3,24-diamino-24-oxocholan-12-yl]-, 1,1-dimethylethyl esterAnticancer therapyamide Bode, Catherine A.et.al (2009)

DOI

cpd009831190101-29-1RIKPHQGQHIGQFPQIMmeso-porphyrin derivativeAnticancer therapy, photosensitizingamide Bakleh, M.et.al (2009)

DOI

cpd009841190101-28-0RIKPHQGQHIGQFPQIMmeso-porphyrin derivativeAnticancer therapy, photosensitizingamide Bakleh, M.et.al (2009)

DOI

cpd009851186099-39-7tripeptideEEENaproxenbone-targeting (prodrug)amide Ouyang, Liang;et.al (2009)

DOI

cpd009861186099-37-5tripeptideEEENaproxenbone-targeting (prodrug)amide Ouyang, Liang;et.al (2009)

DOI

cpd009871186099-33-1dipeptideEENaproxenbone-targeting (prodrug)amide Ouyang, Liang;et.al (2009)

DOI

cpd009881186099-29-5tripeptideEEENaproxenbone-targeting (prodrug)amide Ouyang, Liang;et.al (2009)

DOI

cpd009891186099-28-4dipeptideEENaproxenbone-targeting (prodrug)amide Ouyang, Liang;et.al (2009)

DOI

cpd009901186099-27-3tripeptideEEENaproxenbone-targeting (prodrug)amide Ouyang, Liang;et.al (2009)

DOI

cpd009911186099-23-9dipeptideEENaproxenbone-targeting (prodrug)amide Ouyang, Liang;et.al (2009)

DOI